255 related articles for article (PubMed ID: 21536801)
1. CD300F blocks both MyD88 and TRIF-mediated TLR signaling through activation of Src homology region 2 domain-containing phosphatase 1.
Lee SM; Kim EJ; Suk K; Lee WH
J Immunol; 2011 Jun; 186(11):6296-303. PubMed ID: 21536801
[TBL] [Abstract][Full Text] [Related]
2. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
Kim EJ; Lee SM; Suk K; Lee WH
Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides containing ITIM-like sequences of IREM-1 (CD300F) differentially regulate MyD88 and TRIF-mediated TLR signalling through activation of SHP and/or PI3K.
Lee SM; Suk K; Lee WH
Clin Exp Immunol; 2012 Mar; 167(3):438-46. PubMed ID: 22288587
[TBL] [Abstract][Full Text] [Related]
4. SHPS-1 and a synthetic peptide representing its ITIM inhibit the MyD88, but not TRIF, pathway of TLR signaling through activation of SHP and PI3K in THP-1 cells.
Kim EJ; Suk K; Lee WH
Inflamm Res; 2013 Apr; 62(4):377-86. PubMed ID: 23314616
[TBL] [Abstract][Full Text] [Related]
5. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
[TBL] [Abstract][Full Text] [Related]
6. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
[TBL] [Abstract][Full Text] [Related]
7. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
9. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
[TBL] [Abstract][Full Text] [Related]
10. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
Schmitz F; Mages J; Heit A; Lang R; Wagner H
Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
[TBL] [Abstract][Full Text] [Related]
12. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
[TBL] [Abstract][Full Text] [Related]
13. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
Park SJ; Lee AN; Youn HS
Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
[TBL] [Abstract][Full Text] [Related]
14. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
[TBL] [Abstract][Full Text] [Related]
15. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
16. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
[TBL] [Abstract][Full Text] [Related]
17. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production.
An H; Zhao W; Hou J; Zhang Y; Xie Y; Zheng Y; Xu H; Qian C; Zhou J; Yu Y; Liu S; Feng G; Cao X
Immunity; 2006 Dec; 25(6):919-28. PubMed ID: 17157040
[TBL] [Abstract][Full Text] [Related]
18. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
20. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
